Strong flows, soft profits — execution risk on new ventures
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
H1 pacing on track: 49% of revenue, 52% of PAT guidance delivered. Q1 implied ₹150 Cr PAT, Q2 ₹89 Cr shows sharp decline.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong AUM growth momentum (₹4.2B net flows, 39% YoY) and execution on new initiatives (AMC, GIFT, structured products) offset near-term PAT headwind: down 10.6% YoY despite 15.7% revenue growth, signaling margin compression from cost inflation and one-time ESOP charges. Guidance implied maintained but not reaffirmed; Q2 QoQ PAT decline of 45.2% raises H2 visibility concerns.
₹344 Cr
Revenue · +15.7% YoY₹89.3 Cr
Reported PAT · −10.6% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
PAT grew 23% YoY after tax adjustments
OVERSTATEDReported PAT ₹89.3 Cr down 10.6% YoY; adjusted PAT (excl. ₹46 Cr non-cash charges) ~₹135 Cr implies ~25% growth but this is non-GAAP
Revenue increased 17% YoY
OVERSTATEDDelivered ₹344 Cr, 15.7% YoY growth
Highest net flow ever, ₹4,186 Cr, up 39% YoY
METSupports strong AUM momentum; unverified independently but plausible given client acquisition metrics
49% of FY27 revenue guidance penetration in H1
METIf ₹1,415 Cr full-year guidance, 49% = ₹693 Cr for H1; aligns with stated ~₹357 Cr for first half
Earnings quality
What changed since the last call
ESOP and mark-to-market charges materialized
DowngradeQ2 saw ₹46 Cr one-time charges vs. zero in Q2 FY26; management claimed this would reduce next year but provided no forecast.
Structured products strategy clarified
NewFeroze spent heavily detailing MLD issuances (₹2.8B total) and back-testing (94% win rate), but no revenue or margin contribution disclosed; perceived as future growth engine, not current.
Near-term PAT growth concern flagged
DowngradeManagement stated 20-25% PAT growth as a concern threshold if not met; Q2 actual -10.6% YoY triggers this concern. Prior call implied full-year 25% PAT guidance; now hedged.
AUM target refined
Maintained₹1.2L Cr FY27 target reiterated; net flow guidance narrowed to ₹6,000-₹8,000 Cr with 2-3% mark-to-market as most volatile component.
The Q&A
Analysts pressed hard on 20-25% PAT growth sustainability (Prayesh Jain), UHNI yield parity (Shreink Mehta), MLD complexity (Jyoti Khatri), cost trajectory (Sucrit Patil), and capacity constraints (Sanil). Feroze answered directly on most, though MLD explanation was lengthy/technical. Defensive tone on near-term but did not capitulate on strategy.
PAT growth outlook — Prayesh Jain, Motilal Oswal
PartialNo. Near-term slowdown is normal; we rely on RM talent and market conditions. Mistakes happen. Long-term thesis unchanged.
UHNI wallet concentration — Shreink Mehta, IndoAsia
AnsweredTop 100 clients represent >50% of platinum wallet. Yield marginally better, not premium. Economies of scale add value-adds, not fee discounts.
Execution priorities — Sucrit Patil, Eyesight Fintrack
AnsweredFour engines: (1) client performance (12% target), (2) capacity utilization (431 RMs, can handle 8,000 more), (3) new plant/machinery (500 new RMs identified, being trained), (4) wallet penetration (deliver 5-6% Jensen's Alpha).
Non-cash charges — Milind Kulkarni, MLDL
Answered₹46 Cr is ESOP and mark-to-market; Q2 FY26 was zero. Will reduce next year but timeline not specified.
AUM growth breakdown — Arun Gopal, Retiree
AnsweredTarget ₹1.2L Cr AUM for FY27. Net flow guidance ₹6,000-₹8,000 Cr. Mark-to-market 2-3% guidance, most volatile. Nifty down 5% last quarter cost ₹2,000 Cr in mark-to-market.
Structured products (MLDs) — Jyoti Khatri, Ambit Wealth
AnsweredStructured products require NBFC with derivative hedging. Back-tested 94% success. Longest win streak 1,190 products (Dec 2020–May 2026). Embedded derivatives, delta-hedged. Design uses Monte Carlo simulator with 90% target outcomes.
GIFT City revenue opportunity — Nikhil Agarwal, Choice International
PartialIndia-centric organization. Will deliver Indian resident proposition as well as NRI-focused tax-efficient structured products. Will not count eggs today; proof of concept required before revenue targets.
AMC license timeline — Sunil Shah, SRE PMS
AnsweredApplied month-end October; expect filing by 20th October. Almost all data prepared. Expect good news by January 2027 results (Q3 FY27).
Guidance
FY27 full-year ₹1,415 Cr (implied from 49% H1 penetration)
HighH1 shows 49% delivery; aligned with ₹357 Cr stated revenue for first half. Requires ~₹722 Cr H2, or 9% QoQ growth; achievable given 6.8% Q2 QoQ pace.
PAT ₹460 Cr for FY27 (implied); OPM maintained 34%+, NPM 25%+
MediumH1 PAT implied ~₹239 Cr (52% of ₹460 Cr). Requires ~₹221 Cr H2 PAT, or 40.9% of full-year. Q2 decline to ₹89 Cr suggests cost/charge pressure; management claims ESOP will reduce.
Risks the call surfaced
Market volatility & AUM dependency
MediumMark-to-market guidance 2-3% is most volatile AUM component. Nifty down 5% in Q2 cost ₹2B in AUM. Guidance tied to ₹1.2L Cr AUM target dependent on stable/positive market.
Cost inflation & margin compression
HighESOP charges ₹46 Cr in Q2 (zero in Q2 FY26) impacted PAT. QoQ PAT down 45.2% despite 6.8% revenue growth. Employee cost inflation cited as ongoing headwind; trajectory unclear.
Structured products & regulatory complexity
MediumStructured products (MLDs) strategy heavily touted (30% of call time) but unproven on revenue/profitability. Products are highly leveraged with embedded derivatives; client education and regulatory acceptance key. Back-testing success (94%) does not guarantee market acceptance.
Capacity constraints & RM bottleneck
MediumManagement identified 500 new relationship managers (RMs) needed; capacity currently 431 RMs handling 8,000+ client families. Slow RM ramp could bottleneck new client acquisitions and wallet expansion.
New venture execution risk
MediumThree new initiatives (AMC license filing, GIFT City, UK operations) are early-stage. AMC license approval timeline uncertain (expected Q3 FY27). GIFT City and UK are greenfield; profitability/timeline unquantified.
Management
Score 7/10. Direct on strategy and mechanics; answered most Q&A questions with specificity. Long-winded on structured products (30 min+); occasional deflection on near-term PAT guidance. Strong track record: 20 quarters of PAT growth >20% since listing (Dec 2021). H1 FY27 on track (49% revenue, 52% PAT penetration). Q2 QoQ PAT decline (-45.2%) signals execution headwind, but attributed to one-time charges.
1 · Oct 2026
AMC license filing expected to complete; regulatory approval timeline TBD
2 · H2 FY27
GIFT City operations launch in India; London UK subsidiary ramp
3 · Jan 2027
Q3 FY27 results; management signals 'good news' on AMC approval expected by then
Guidance implied maintained but not reaffirmed; Q2 QoQ PAT decline of 45.2% raises H2 visibility concerns.
Informational and educational content only. Not investment advice.